Telomere length predicts for outcome to FCR chemotherapy in CLL

We have previously shown that dividing patients with CLL into those with telomeres inside the fusogenic range (TL-IFR) and outside the fusogenic range (TL-OFR) is powerful prognostic tool. Here, we used a high-throughput version of the assay (HT-STELA) to establish whether telomere length could pred...

Descripción completa

Detalles Bibliográficos
Autores principales: Norris, Kevin, Hillmen, Peter, Rawstron, Andrew, Hills, Robert, Baird, Duncan M., Fegan, Christopher D., Pepper, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756045/
https://www.ncbi.nlm.nih.gov/pubmed/30700843
http://dx.doi.org/10.1038/s41375-019-0389-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756045/
https://www.ncbi.nlm.nih.gov/pubmed/30700843
http://dx.doi.org/10.1038/s41375-019-0389-9

Ejemplares similares